Clinical assessment of renal disease
Acute renal failure (ARF)
Acute renal failure is the failure of renal function over a period of hours or days and is
defined by increasing serum creatinine and urea. It is a life-threatening disorder caused
by the retention of nitrogenous waste products and salts such as sodium and potassium.
The rise in potassium may cause ECG changes and a risk of cardiac arrest. Acute renal
failure may be classified into pre-renal, renal and post-renal. Prompt identification of
pre- or post-renal factors and appropriate treatment action may allow correction before
damage to the kidneys occurs. Pre-renal failure occurs due to a lack of renal perfusion.
This can occur in volume loss in haemorrhage, gastrointestinal fluid loss and burns or
because of a decrease in cardiac output caused by cardiogenic shock, massive pulmonary
embolus or cardiac tamponade (application of pressure) or other causes of hypertension
such as sepsis. Post-renal causes include bilateral uretic obstruction because of calculi
or tumours or by decreased bladder outflow/urethral obstruction e.g. urethral stricture or
prostate enlargement through hypertrophy of carcinoma. Correction of the underlying
problem can avoid any kidney damage. Renal causes of acute renal failure include glom-
erular nephritis, vascular disease, severe hypertension, hypercalcaemia, invasive disorders
such as sarcoidosis or lymphoma and nephrotoxins including animal and plant toxins,
heavy metals, aminoglycosides, antibiotics and non-steroidal anti-inflammatory drugs.
Chronic kidney disease (CKD)
CKD is a progressive condition characterised by a decliningeGFR (Table 16.6). All CKD
patients are subject to regular clinical and laboratory assessment and once Stage 3 has
been reached to additional clinical management. This is aimed at attempting to
reverse or arrest the disease by drug therapy saving the patient the inconvenience
and the paying authority the cost of dialysis or transplantation.
16.3.5 Endocrine disorders
Endocrine hormones are synthesised in the brain, adrenal, pancreas, testes and ovary,
and most importantly in the hypothalamus and pituitary, but they act elsewhere in
Table 16.6Stages of chronic kidney disease (CKD)
CKD stage
eGFR (cm^3 min^1
1.73 m^2 ) Clinical relevance
1 > 90 Regard as normal unless other symptoms presenta
2 60–89 Regard as normal unless other symptoms presenta
3 30–59 Moderate renal impairment
4 15–29 Severe renal impairment
5 < 15 Advanced renal failure
Note:aSymptoms include persistent proteinuria, haematuria, weight loss, hypertension.
649 16.3 Examples of biochemical aids to clinical diagnosis